Before Invest
GILEAD SCIENCES, INC. logo

GILEAD SCIENCES, INC.

GILD
Biological Products No Disgnostic Substances
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 40 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Current assets:
                                                    
Cash and cash equivalents
$ 3,179
$ 7,628
$ 7,330
$ 5,144
$ 7,926
$ 5,037
$ 2,772
$ 4,718
$ 5,705
$ 5,704
$ 4,936
$ 4,699
Assets
                                                    
Short-term marketable debt securities
0
15
19
69
-
0
0
0
1,159
963
936
961
Accounts receivable, net
5,055
4,741
5,095
4,781
4,388
4,587
4,663
4,669
4,790
4,229
4,162
4,354
Inventories
1,953
1,914
1,785
1,825
1,759
1,869
2,026
1,853
1,663
1,633
1,576
1,463
Deferred tax assets
2,487
1,767
1,998
2,721
2,572
-
-
-
-
-
-
-
Prepaid and other current assets
3,759
4,342
3,645
2,899
2,828
3,287
2,856
2,800
2,662
1,757
1,846
2,077
Prepaid taxes
-
-
-
-
-
-
-
-
-
-
-
-
Prepaid expenses
-
-
-
-
-
-
-
-
-
-
-
-
Other current assets
-
-
-
-
-
-
-
-
-
-
-
-
Total current assets
13,945
18,641
17,874
14,718
16,901
14,779
12,317
14,041
15,980
14,287
13,456
13,554
Noncurrent Assets
                                                    
Property, plant and equipment, net
5,833
5,638
5,500
5,459
5,421
5,391
5,346
5,321
5,572
5,540
5,479
5,349
Long-term portion of prepaid royalties
-
-
-
-
-
-
-
-
-
-
-
-
Long-term deferred tax assets
-
-
-
-
-
-
-
-
-
-
-
-
Long-term marketable debt securities
0
983
2,005
1,913
-
0
0
0
1,156
1,334
1,327
1,282
Intangible assets, net
14,032
16,382
17,970
18,566
19,355
20,546
22,832
23,428
27,152
27,750
28,348
29,440
Goodwill
8,314
8,314
8,314
8,314
8,314
8,314
8,314
8,314
8,314
8,314
8,314
8,314
Intangible assets
-
-
-
-
-
-
-
-
-
-
-
-
Other long-term assets
4,751
4,554
4,873
4,031
3,871
5,494
4,770
5,188
4,200
5,113
4,952
4,618
Total assets
49,362
56,278
58,533
55,721
56,434
54,525
53,579
56,292
62,373
62,337
61,876
62,557
Liabilities and Stockholders’ Equity
                                                    
Current liabilities:
                                                    
Accounts payable
674
645
808
582
737
903
537
622
586
622
627
614
Accrued rebates
4,233
4,118
4,931
4,215
4,185
4,113
3,923
4,263
3,714
3,494
3,477
3,674
Accrued compensation and employee benefits
-
-
-
-
-
-
-
-
-
-
-
-
Income taxes payable
-
-
-
-
-
-
-
-
-
-
-
-
Accrued and other current liabilities
-
-
-
-
-
-
-
-
-
-
-
3,865
Deferred revenues
-
-
-
-
-
-
-
-
-
-
-
-
Current portion of long-term debt, net
2,414
1,313
2,806
2,806
2,806
1,812
1,810
3,667
1,793
4,037
2,283
2,270
Other current liabilities
3,699
3,399
3,752
3,586
4,615
4,896
4,510
4,464
5,852
5,810
4,140
-
Total current liabilities
11,020
9,476
12,298
11,189
12,344
11,725
10,781
13,015
11,945
13,964
10,528
10,423
Noncurrent Liabilities
                                                    
Long-term deferred revenues
-
-
-
-
-
-
-
-
-
-
-
-
Long-term debt, net
23,832
20,861
22,135
22,140
22,146
21,437
21,540
21,527
23,189
21,209
22,956
22,953
Long-term income taxes payable
943
918
866
859
819
782
738
1,967
2,088
2,610
3,775
3,982
Deferred tax liabilities
333
392
597
652
709
794
907
933
1,984
2,106
2,401
3,036
Convertible senior notes, net
-
-
-
-
-
-
-
-
-
-
-
-
Other long-term liabilities
1,490
1,200
1,182
1,290
1,337
1,396
1,418
1,395
924
1,354
1,277
1,106
Equity Component of Currently Redeemable Convertible Notes
                                                    
Equity component of currently redeemable convertible notes
-
-
-
-
-
-
-
-
-
-
-
-
Stockholders’ equity:
                                                    
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding
0
0
0
0
0
0
0
0
0
0
0
0
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,241 shares issued and outstanding
1
1
1
1
1
1
1
1
1
1
1
1
Additional paid-in capital
9,532
9,305
8,678
8,367
8,138
7,327
7,022
6,813
6,279
6,008
5,793
5,226
Accumulated other comprehensive income
95
78
36
(18)
92
73
93
69
31
10
(20)
98
Retained earnings
2,200
14,131
12,825
11,325
10,931
11,073
11,165
10,656
16,002
15,138
15,223
15,756
Total Gilead stockholders’ equity
11,829
23,515
21,540
19,674
19,162
18,475
18,281
17,539
22,314
21,158
20,997
21,081
Noncontrolling interest
(84)
(84)
(84)
(84)
(84)
(84)
(84)
(84)
(72)
(64)
(58)
(24)
Total stockholders’ equity
11,744
23,431
21,456
19,590
19,078
18,390
18,197
17,455
22,242
21,094
20,939
21,057
Total liabilities and stockholders’ equity
$ 49,362
$ 56,278
$ 58,533
$ 55,721
$ 56,434
$ 54,525
$ 53,579
$ 56,292
$ 62,373
$ 62,337
$ 61,876
$ 62,557